Savara

SVRA · NASDAQ

$4.76+$0.13 (+2.81%)TodayMarket closed ·
Prev close $4.63

Who owns SVRA

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 62.6% of SVRA’s shares.

  • New Enterprise Associates (NEA)11.9%
  • Bain Capital Life Sciences Investors, LLC8.6%
  • VR Adviser, LLC7.2%
  • Deerfield Management Company, L.P.6.6%
  • Next 6 largest institutions28.2%
  • All other shareholders37.4%
Top institutional holders of SVRA
HolderShares% of shares
New Enterprise Associates (NEA)24.47M11.94%
Bain Capital Life Sciences Investors, LLC17.60M8.59%
VR Adviser, LLC14.75M7.20%
Deerfield Management Company, L.P.13.57M6.62%
TCG Crossover Management, LLC12.36M6.03%
BlackRock Institutional Trust Company, N.A.11.30M5.51%
Frazier Life Sciences Management, L.P.9.72M4.74%
Polar Capital LLP9.54M4.66%
Vanguard Capital Management, LLC7.93M3.87%
Nantahala Capital Management, LLC6.98M3.40%

Largest mutual fund holders

Top mutual fund holders of SVRA
HolderShares% of shares
Polar Capital Funds Plc - Healthcare Opportunities Fund8.19M4.00%
Vanguard Total Stock Market Index Fund6.16M3.01%
iShares Russell 2000 ETF3.99M1.94%
State Street SPDR S&P Biotech ETF3.37M1.65%
Polar Capital Biotechnology Fund1.82M0.89%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $2.24M (1 trade) of SVRA on the open market, with no buys.

Latest SVRA insider transactions
InsiderTypeSharesValue
Parker Braden C.Tax withholding29.32K$148.67K
Lutz Robert MatthewAward70.00K—
Lutz Robert MatthewAward35.00K—
Lowrance David LOption exercise87.65K—
Lowrance David LOption exercise12.50K—
Lowrance David LOption exercise218.75K—
Lowrance David LOption exercise56.94K—
Lowrance David LOption exercise129.35K—
Lowrance David LOption exercise75.00K—
Lowrance David LSale394.53K$2.24M

Short interest

Settled Sep 30, 2026

Shares short
43.56M
Days to cover
17.24
% of shares outstanding
21.26%
Average daily volume
2.53M
Change since last report
+0.5%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.